Your browser doesn't support javascript.
loading
Prevention of post-contrast kidney injury in patients with cancer.
Grassedonio, Emanuele; Incorvaia, Lorena; Guarneri, Marco; Guagnini, Fabio; Midiri, Massimo.
Afiliação
  • Grassedonio E; Biomedicine Department, Neuroscience and Advance Diagnostics, University of Palermo, Palermo, Italy.
  • Incorvaia L; Department of Precision Medicine in Medical, Surgical and Critical Care (Me.Pre.C.C.), Section of Medical Oncology, University of Palermo, Palermo, Italy.
  • Guarneri M; Nephrology and Dialysis, Azienda Ospedaliera Universitaria "Paolo Giaccone" Polyclinic, Palermo, Italy.
  • Guagnini F; GE HealthCare Pharmaceutical Diagnostic (PDx), Milan, Italy.
  • Midiri M; Biomedicine Department, Neuroscience and Advance Diagnostics, University of Palermo, Palermo, Italy.
Drugs Context ; 132024.
Article em En | MEDLINE | ID: mdl-38510312
ABSTRACT
Post-contrast acute kidney injury is defined as a nephropathy with an increase in serum creatinine of >0.3 mg/dL (or >26.5 µmol/L) or >1.5-times the baseline within 48-72 h of intravascular administration of a contrast medium. Patients with cancer have an increased risk of post-contrast acute kidney injury not only related to the frequent use of contrast medium for computed tomography scans but also to other factors, including the type of tumour, age, oncological therapies, use of other nephrotoxic agents and dehydration. Preventive strategies were developed and may be applied to different risk profiles. Patients at risk may be detected by recently published risk scores.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Drugs Context Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Itália

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Drugs Context Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Itália